1. Home
  2. APRE vs NWGL Comparison

APRE vs NWGL Comparison

Compare APRE & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • NWGL
  • Stock Information
  • Founded
  • APRE 2006
  • NWGL 2008
  • Country
  • APRE United States
  • NWGL Macau
  • Employees
  • APRE N/A
  • NWGL N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • NWGL
  • Sector
  • APRE Health Care
  • NWGL
  • Exchange
  • APRE Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • APRE 21.3M
  • NWGL 23.7M
  • IPO Year
  • APRE 2019
  • NWGL 2023
  • Fundamental
  • Price
  • APRE $2.92
  • NWGL $1.40
  • Analyst Decision
  • APRE Strong Buy
  • NWGL
  • Analyst Count
  • APRE 2
  • NWGL 0
  • Target Price
  • APRE $15.50
  • NWGL N/A
  • AVG Volume (30 Days)
  • APRE 13.3K
  • NWGL 5.3K
  • Earning Date
  • APRE 11-07-2024
  • NWGL 11-29-2024
  • Dividend Yield
  • APRE N/A
  • NWGL N/A
  • EPS Growth
  • APRE N/A
  • NWGL N/A
  • EPS
  • APRE N/A
  • NWGL N/A
  • Revenue
  • APRE $1,310,839.00
  • NWGL $25,456,775.00
  • Revenue This Year
  • APRE $116.72
  • NWGL N/A
  • Revenue Next Year
  • APRE N/A
  • NWGL N/A
  • P/E Ratio
  • APRE N/A
  • NWGL N/A
  • Revenue Growth
  • APRE 130.31
  • NWGL N/A
  • 52 Week Low
  • APRE $2.15
  • NWGL $1.24
  • 52 Week High
  • APRE $8.85
  • NWGL $21.97
  • Technical
  • Relative Strength Index (RSI)
  • APRE 34.50
  • NWGL 43.90
  • Support Level
  • APRE $2.87
  • NWGL $1.43
  • Resistance Level
  • APRE $3.35
  • NWGL $1.66
  • Average True Range (ATR)
  • APRE 0.32
  • NWGL 0.11
  • MACD
  • APRE -0.12
  • NWGL -0.00
  • Stochastic Oscillator
  • APRE 4.50
  • NWGL 16.84

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: